Long-term Treatment Outcome for Stage III NPC Patients and Risk Grouping by Plasma EBV DNA
NCT03314051
·
clinicaltrials.gov ↗
COMPLETED
Status
366
Enrollment
OTHER
Sponsor class
Conditions
Nasopharyngeal Carcinoma
EBV Related Carcinoma
Sponsor
Taichung Veterans General Hospital